Publications by authors named "David Berd"

Claim this Profile
P
Portrait of an autologous cancer vaccine: Then and now.
David Berd

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases.
Matias E Valsecchi, Mizue Terai, David J Eschelman, Carin F Gonsalves, Inna Chervoneva, David Berd

J Vasc Interv Radiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tale of two pities: autologous melanoma vaccines on the brink.
David Berd

Hum Vaccin Immunother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 6 mediates production of interleukin 10 in metastatic melanoma.
Mizue Terai, Masumi Eto, Garbo D Young, David Berd, Michael J Mastrangelo

Cancer Immunol Immunother· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
Adam C Berger, Michael Fierro, John C Kairys, David Berd, Takami Sato

J Surg Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.
Amit Mahipal, Mizue Terai, David Berd, Inna Chervoneva, Kashyap Patel

Cancer Immunol Immunother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential.
Mizue Terai, Yutaka Tamura, Vitali Alexeev, Eiko Ohtsuka, David Berd

Cancer Immunol Immunother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.
Akira Yamamoto, Inna Chervoneva, Kevin L Sullivan, David J Eschelman, Carin F Gonsalves, David Berd

Radiology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.
Takami Sato, David J Eschelman, Carin F Gonsalves, Mizue Terai, Inna Chervoneva, David Berd

J Clin Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
Magdolna Solti, David Berd, Michael J Mastrangelo, Takami Sato

Melanoma Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whipsaw cancer treatments: the role of hormesis in endocrine and immune therapies.
Richmond T Prehn, David Berd

Semin Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calculation of survival of patients with stage III melanoma.
David Berd, Michael J Mastrangelo, Takami Sato

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study.
Kashyap Patel, Kevin Sullivan, David Berd, Michael J Mastrangelo, Carol L Shields

Melanoma Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M-Vax: an autologous, hapten-modified vaccine for human cancer.
David Berd

Expert Rev Vaccines· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine.
David Berd, Takami Sato, Henry C Maguire, John Kairys, Michael J Mastrangelo

J Clin Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
Takami Sato, Mizue Terai, Rie Yasuda, Ryuko Watanabe, David Berd

Cancer Immunol Immunother· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells.
Ronald A Coss, Christopher W Storck, Constantine Daskalakis, David Berd, Miriam L Wahl

Mol Cancer Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine.
David Berd

Vaccine· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine.
Jayanthi Manne, Michael J Mastrangelo, Takami Sato, David Berd

J Immunol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses.
David Berd, Takami Sato, Michael J Mastrangelo

Cancer Immunol Immunother· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is human aging still mysterious enough to be left only to scientists?
Aubrey D N J de Grey, John W Baynes, David Berd, Christopher B Heward, Graham Pawelec

Bioessays· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of intracellular pH in human melanoma: potential therapeutic implications.
Miriam L Wahl, Judith A Owen, Randy Burd, Robin A Herlands, Suzanne S Nogami, David Berd

Mol Cancer Ther· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M-Vax: an autologous, hapten-modified vaccine for human cancer.
David Berd

Expert Opin Biol Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis